Navigation Links
Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback
Date:11/8/2013

SAN DIEGO, Nov. 8, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today it has been recognized as one of U-T San Diego's Top Workplaces. The Top Workplaces are determined exclusively based on employee feedback provided through an anonymous survey.

"We are extremely honored that our employees' feedback has resulted in this recognition," said Ted Schroeder, President, CEO, and co-founder of Cadence Pharmaceuticals. "Building and sustaining a great working environment and a strong culture has been a top priority since we founded the company in 2004. The leadership team is focused on driving competitive advantage by consistently fostering a strong set of core values and maintaining our dynamic company culture."

The survey, which was conducted by leading research firm on organizational health and employee engagement, WorkplaceDynamics, LLP, included questions around company direction, execution, connection to the company, management, pay and benefits, and employee engagement. Cadence Pharmaceuticals had an exceptional 92 percent employee response rate on the survey.

"The key to Cadence Pharmaceuticals' employee satisfaction is a culture that encourages employee feedback," said Diane Sheehan, Vice President of Human Resources at Cadence Pharmaceuticals. "Each employee is important to our success, so it is imperative that we gather, consider and take action on their input. We believe that this approach will help as we strive to achieve our corporate objectives and provide value to the hospital community and our business partners."

The following anonymous testimonials were excerpted from the survey:

  • "I truly believe in the product I promote and believe I work with the best people in the industry. Management is transparent and supportive all the way up the chain of command. I have never been more satisfied with work."
  • "I am empowered to make decisions and contribute. Our CEO is accessible and easy to approach. [Cadence Pharmaceuticals has a] strong unique culture in which we can all contribute and be a part of the company's success."

In addition, Cadence Pharmaceuticals was recognized as a recipient of a 2013 Workplace Excellence Award presented by the San Diego Society for Human Resource Management's (SD SHRM). This award, which is based on the assessment of an expert judging panel assembled by SD SHRM, recognizes Cadence Pharmaceuticals' proactive efforts to involve its employees in the ongoing strengthening of the company and its culture. This is the second time Cadence Pharmaceuticals has won a SD SHRM Workplace Excellence Award, with the first award in 2010.

Both awards were presented at a ceremony sponsored by U-T San Diego, held at the Hilton La Jolla Torrey Pines on November 7, 2013.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."

Cadence® is a trademark of Cadence Pharmaceuticals, Inc.

Investor Contact:
William R. LaRue   
SVP & Chief Financial Officer    
Cadence Pharmaceuticals, Inc.       
Phone: 858-436-1400                                                                                     

Media Contact:
Cuyler Mayer     
Edelman
Phone: 323-202-1073


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
4. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
5. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
6. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
7. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
8. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
9. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
11. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  As National Nutrition ... addition, the Company is helping people live healthier ... customized prescription savings programs in all 50 states ... Assistance Program  and  California Prescription Assistance Program . ... Columbia University for nutritious eating habits: ...
(Date:2/23/2017)... MARIETTA, Ga., Feb. 23, 2017  MiMedx Group, Inc. ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of ... quarter and full year ended December 31, 2016. ... Revenue is a 31% increase over full year ...
(Date:2/23/2017)... Korea , Feb. 23, 2017 LG Innotek today ... LED for sterilization applications. As its sterilization performance is 1.5 times ... the short wavelength ultraviolet rays in the range of 200 -- 280nm, ... proliferation of bacteria by destroying their DNA. LG Innotek,s product emits ... ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... jointly issued a letter to withdraw previous guidance issued by the ... identity. The guidance issued in May 2016 by the Obama Administration came in ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... approved content provider for the National Institute for Health and Care Excellence ... care-related organizations in the National Health Service (NHS) to search, order and purchase ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in clinical trials, today announced that Premier Research, a leading clinical development service ... Clinical trials are becoming increasingly complex, due in part to an array of ...
(Date:2/23/2017)... ... (PRWEB) February 23, 2017 -- ... to come together to combine its favorite springtime pastime – ... fruit – apples! To celebrate National Nutrition Month, the U.S. ... Madness” bracket tournament – a five-week, five-round online competition spotlighting ...
Breaking Medicine News(10 mins):